We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+25.21%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$13.9M
AUM Growth
-$44.5M
Cap. Flow
-$44.7M
Cap. Flow %
-320.95%
Top 10 Hldgs %
48.07%
Holding
80
New
14
Increased
3
Reduced
23
Closed
39
Avg Time Held Equity + Options
3.3 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.9 quarters
Avg Time Held Equity only
3.3 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$510K
2
ELV icon
Elevance Health
ELV
+$459K
3
HUM icon
Humana
HUM
+$427K
4
CNC icon
Centene
CNC
+$371K
5
PFE icon
Pfizer
PFE
+$281K

Sector Composition

Rank Sector Weight
1 Healthcare 99.1%
2 Miscellaneous 0.9%
3 Communication Services 0%
4 Consumer Discretionary 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LVGO
76
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-1,444
Closed -$25K –
DLPH
77
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
– –
-14,179
Closed -$190K –
WCG
78
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-4,757
Closed -$1.23M –

Similar funds

Partner Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Partner Investment Management held 80 positions worth $13.9M, down 76% from $58.4M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Partner Investment Management withdrew a net $44.7M in Q4 2019, closing 39 positions and reducing 23 holdings. Its most notable exit was NXP Semiconductors, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 53% a quarter earlier, followed by Miscellaneous and Communication Services.

Against the trend, Partner Investment Management opened a new position in Biogen worth $546K.

  • Partner Investment Management's largest Q4 2019 buy was Biogen: 1,839 shares worth $546K.
  • Partner Investment Management added most to Axonics, Inc. Common Stock in Q4 2019, an estimated $48.7K increase.
  • Partner Investment Management's biggest Q4 2019 reduction was Zimmer Biomet, cutting an estimated $1.99M.
  • Partner Investment Management fully exited NXP Semiconductors in Q4 2019, selling an estimated $2.23M.
  • Partner Investment Management's ten largest holdings make up 48% of its $13.9M portfolio in Q4 2019.
  • Partner Investment Management opened 14 new positions and closed 39 in Q4 2019.
  • Partner Investment Management's portfolio value fell 76% quarter-over-quarter to $13.9M.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.